Prot #AEZS-108-050: Randomized controlled study comparing AEZS-108 with doxorubicin as second line therapy for locally advanced, recurrent or metastatic endometrial cancer

  • Pineda, Mario Javier (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/25/143/25/17

Funding

  • Ergomed Clinical Research Inc. (Prot #AEZS-108-050)
  • Æterna Zentaris Inc. (Prot #AEZS-108-050)